Avidity Biosciences Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RNAM has 155.15 million shares outstanding. The number of shares has increased by 23.42% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 155.15M |
| Shares Change (YoY) | +23.42% |
| Shares Change (QoQ) | +11.68% |
| Owned by Insiders (%) | 5.95% |
| Owned by Institutions (%) | 85.46% |
| Float | 132.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.20, with a Debt / Equity ratio of 0.03.
| Current Ratio | 9.20 |
| Quick Ratio | 8.75 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.98% and return on invested capital (ROIC) is -29.42%.
| Return on Equity (ROE) | -43.98% |
| Return on Assets (ROA) | -26.47% |
| Return on Invested Capital (ROIC) | -29.42% |
| Return on Capital Employed (ROCE) | -42.32% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $36,703 |
| Profits Per Employee | -$1.34M |
| Employee Count | 511 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +144.73% in the last 52 weeks. The beta is 0.93, so RNAM's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | +144.73% |
| 50-Day Moving Average | 72.52 |
| 200-Day Moving Average | 52.68 |
| Relative Strength Index (RSI) | 58.43 |
| Average Volume (20 Days) | 4,222,274 |
Short Selling Information
The latest short interest is 10.16 million, so 6.55% of the outstanding shares have been sold short.
| Short Interest | 10.16M |
| Short Previous Month | 8.75M |
| Short % of Shares Out | 6.55% |
| Short % of Float | 7.68% |
| Short Ratio (days to cover) | 5.07 |
Income Statement
In the last 12 months, RNAM had revenue of $18.76 million and -$684.63 million in losses. Loss per share was -$4.97.
| Revenue | 18.76M |
| Gross Profit | -540.40M |
| Operating Income | -745.94M |
| Pretax Income | -684.63M |
| Net Income | -684.63M |
| EBITDA | -741.79M |
| EBIT | -745.94M |
| Loss Per Share | -$4.97 |
Balance Sheet
The company has $1.70 billion in cash and $49.25 million in debt, with a net cash position of $1.65 billion or $10.62 per share.
| Cash & Cash Equivalents | 1.70B |
| Total Debt | 49.25M |
| Net Cash | 1.65B |
| Net Cash Per Share | $10.62 |
| Equity (Book Value) | 1.69B |
| Book Value Per Share | 11.17 |
| Working Capital | 1.60B |
Cash Flow
In the last 12 months, operating cash flow was -$650.44 million and capital expenditures -$13.32 million, giving a free cash flow of -$663.76 million.
| Operating Cash Flow | -650.44M |
| Capital Expenditures | -13.32M |
| Free Cash Flow | -663.76M |
| FCF Per Share | -$4.28 |
Margins
| Gross Margin | n/a |
| Operating Margin | -3,977.30% |
| Pretax Margin | -3,650.39% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RNAM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.42% |
| Shareholder Yield | -23.42% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RNAM has an Altman Z-Score of 11.03 and a Piotroski F-Score of 2.
| Altman Z-Score | 11.03 |
| Piotroski F-Score | 2 |